Astria Therapeutics
Why Robinhood?
You can watch ATXS and buy or sell other stocks, ETFs, and their options commission-free!About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
ATXS Key Statistics
Stock Snapshot
As of today, Astria Therapeutics(ATXS) shares are valued at $12.58. The company's market cap stands at 709.95M, with a P/E ratio of -5.85.
Astria Therapeutics(ATXS) stock opened on 2026-05-03 at —. The price climbed to — and dipped to —.
Astria Therapeutics(ATXS) shares are trading with a volume of 0, against a daily average of 581.79K.
During the past year, Astria Therapeutics(ATXS) stock moved between $3.56 at its lowest and $13.29 at its peak.
During the past year, Astria Therapeutics(ATXS) stock moved between $3.56 at its lowest and $13.29 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.